Table 2.
Author, Year | Population (Health Status, Age) | Diet (Vegetarian, Vegan) Diet Duration | Study Designs Included | Years of Primary Studies | Diet Adherence Assessment Reported | Outcomes of Interest Reported | Meta-Analysis | RoB Assessment | Certainty of Evidence Grading | Overall Confidence in Results from AMSTAR2 |
---|---|---|---|---|---|---|---|---|---|---|
Bakaloudi et al. 2021 [28] | No limits on health status or age | Vegan Duration: NA-11.7 years |
Cross-sectional, cohort | NR |
|
BMI | No | Newcastle-Ottawa and modified Newcastle-Ottawa Scale | No | Low |
Benatar et al. 2018 [29] | No significant comorbidities ≥18 years |
Vegan Duration: ≥1 year |
Cross-sectional, cohort | 1960–2018 |
|
|
Yes | Newcastle-Ottawa Scale | No | Critically Low |
Craddock et al. 2019 [30] | No limits on health status or age | Vegetarian Duration: ≥4 weeks for interventions, ≥1 year for observational |
Cross-sectional, RCTs | NA-2017 | No | CRP | Yes | Modified Newcastle-Ottawa Scale | GRADE | Critically Low |
Dybvik et al. 2022 [31] | Presumably healthy general population No limits on age |
Vegetarian, Vegan Duration: 5.14–28.3 years |
Prospective Cohort Studies | NA-2021 | No |
|
Yes | Modified ROBINS-I | World Cancer Research Fund grading criteria | Low |
Elliot et al. 2022 [32] | No limits on health status ≥18 years |
Vegetarian, Vegan Duration: 3 months- 3.75 years |
RCT, prospective cohort, cross-sectional | NA-2022 | No |
|
No | No | No | Critically Low |
Gibbs et al. 2021 [33] | No limits on health status ≥18 years |
Vegetarian, Vegan Duration: 1.4–204 weeks (median 12 weeks) |
Controlled trials | 1961–2019 | No | BP | Yes | RoB2 | GRADE | Low |
Glenn et al. 2019 [34] | With or without diabetes Median age range: 33–58 years |
Vegetarian Duration: ≥1 year |
Prospective cohort | NA-2018 | Yes |
|
Yes | Newcastle-Ottawa | GRADE | Critically Low |
Ivanova et al. 2021 [35] | No limits on health status ≥18 years |
Vegetarian, Vegan Duration: 30 days-2 years |
Controlled trials, prospective cohort studies | NA-2021 | No |
|
No | Newcastle-Ottawa Scale | No | Critically Low |
Jabri et al. 2021 [36] | No limits on health status or age | Vegetarian Duration: Mean of 10.68 years |
Prospective Cohort Studies | NA-2019 | No |
|
Yes | ROBINS-I | GRADE | Critically Low |
Jafari et al. 2021 [37] | No limit on health status ≥18 years |
Vegetarian, Vegan Duration: 4–25 years |
Prospective Cohort Studies | 1988–2020 | Yes |
|
Yes | Newcastle-Ottawa | GRADE | Low |
Kaiser et al. 2021 [38] | No limits on health status or age | Vegan Duration 8 weeks-18.1 years |
RCTs, Prospective Cohort, Cross-sectional | NR-2020 | Yes |
|
No | Cochrane Collaboration Tool and Newcastle-Ottawa | Agency for Healthcare Research and Quality | Low |
Koch et al. 2023 [47] | No limit on health status ≥18 years |
Vegetarian, Vegan | RCTs | 1980–2022 | No | LDL-C TGs |
Yes | RoB 2 | No | Critically Low |
Lee et al. 2020 [39] | No limits on health status or age | Vegetarian, Vegan Duration: ≥ 2 weeks |
RCTs | NA-2020 | No | BP | Yes | RoB | GRADE | Critically Low |
Lopez et al. 2019 [40] | No limit on health status ≥18 years |
Vegan Duration: ≥3 weeks |
RCTs | NA-2018 | No | BP | Yes | NR | GRADE | Low |
Lu et al. 2021 [41] | No history of stroke No limits on age |
Vegetarian Duration: 6–26 years |
Prospective Cohort Studies | NA-2021 | Yes | Stroke Incidence | Yes | Newcastle-Ottawa | Nutrigrade | High |
Menzel et al. 2020 [42] | No limit on health status ≥18 years |
Vegetarian, Vegan Duration: 1–25 years |
Cross-sectional | NA-2020 | No | CRP | Yes | Newcastle-Ottawa Quality Assessment Scale adapted for cross-sectional studies | No | Low |
Pollakova et al. 2021 [43] | Healthy ≥18 years |
Vegan Duration: 6–74 weeks |
RCTs | NR-2020 | No | BMI | No | Cochrane Risk of Bias tool | No | Critically Low |
Quek et al. 2021 [44] | No limit on health status 38–67 years |
Vegetarian Duration: NR |
Prospective Cohort Studies | NA-2021 | Yes |
|
Yes | Newcastle-Ottawa | No | Critically Low |
Rees et al. 2021 [45] | General Population or with CVD Risk | Vegan Duration: 8–39 weeks |
RCTs | 1900–2020 | No |
|
Yes | RoB2 | GRADE (for some outcomes) | High |
Remde et al. 2022 [46] | No limit on health status Adult |
Vegetarian, Vegan Duration: ≥4 weeks |
RCTs and Quasi-experimental studies | NR-2020 | No |
|
No | Cochrane RoB | No | Low |
Wang et al. 2023 [48] | No limit on health status ≥18 years |
Vegetarian Duration: 2–36 years |
Prospective cohort studies, case-cohort studies, or nested case-control studies |
NR- 2023 | Yes |
|
Yes | Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies | No | Critically Low |
Abbreviations: AMSTAR2= A MeaSurement Tool to Assess systematic Reviews version 2, BMI= body mass index, BP= blood pressure, CBVD= cerebrovascular disease, CRP= C-reactive protein, CHD= coronary heart disease, CVD= cardiovascular disease, GRADE= Grading of Recommendations, Assessment, Development, and Evaluations, IHD= ischemic heart disease, hsCRP= high-sensitivity c-reactive protein, LDL-C= low-density lipoprotein cholesterol, NA= not applicable, NR= not reported, RCT= randomized controlled trial, ROB= risk of bias, RoB2= Version 2 of the Cochrane risk-of-bias tool for randomized trials, ROBINS-I= Risk Of Bias In Non-Randomized Studies - of Interventions; TGs= triglycerides.